Are omega-3 fatty acids effective in enhancing tumoricidal cell activity?

Journal of Nutrition

Volumn 135, Issue 12, 2005, Pages

  Fritsche, Kevin L ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Anti inflammatory; Eicosanoid; IL 12

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOTRIENE B4; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

CANCER INCIDENCE; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; NATURAL KILLER CELL; NONHUMAN; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR IMMUNITY;

ANIMALIA;

EID: 31544439591     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/135.12.2916s     Document Type: Conference Paper

References (16)

1. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett, WC, Giovannucci EL. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr. 2004;80:204-16.
2. Gago-Dominguez M, Yuan JM, Sun CL, Lee, HP, Yu MC. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer. 2003;89:1686-92.
3. Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr. 2004;134:3427S-30.
4. Reddy BS. Omega-3 fatty acids in colorectal cancer prevention. Int J Cancer. 2004;112:1-7.
5. Wallace JM. Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipoxygenases-as an adjunct in cancer therapy. Integr Cancer Ther. 2002;1:7-37.
6. Larsson SC, Kumlin M, Ingelman-Sundberg, M, Wolk A. Dietary longchain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935-45.
7. Terry PD, Terry JB, Rohan TE. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr. 2004;134:3412S-20.
8. Das UN, Ramos EJ, Meguid MM. Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids. Curr Opin Clin Nutr Metab Care. 2003;6:413-9.
9. Grimble RF. Nutritional therapy for cancer cachexia. Gut. 2003;52:1391-2.
10. Fritsche KL, Anderson, M, Feng C. Consumption of eicosapentaenoic acid and docosahexaenoic acid impair murine interleukin-12 and interferon-gamma production in vivo. J Infect Dis. 2000;182(Suppl 1):S54-61.
11. Irons R, Fritsche KL. Omega-3 polyunsaturated fatty acids impair in vivo interferon- gamma responsiveness via diminished receptor signaling. J Infect Dis. 2005;191:481-6.
12. Purasiri P, McKechnie A, Heys SD, Eremin O. Modulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acids. Immunology. 1997;92:166-72.
13. Almallah YZ, El-Tahir A, Heys SD, Richardson S, Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58-65.
14. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. Am J Clin Nutr. 2001;73:539-48.
15. Salem ML, Kishihara K, Abe K, Matsuzaki G, Nomoto K. N-3 polyunsaturated fatty acids accentuate B16 melanoma growth and metastasis through suppression of tumoricidal function of T cells and macrophages. Anticancer Res. 2000;20:3195-203.
16. Metelitsa LS. Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells. Clin Immunol. 2004;110:267-76.